A phase II study of continuous infusion 5‐fluorouracil in advanced hormone refractory prostate cancer: An Illinois cancer center study

Jacob Lokich*, Timothy M. Kuzel, Martin S. Tallman

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of continuous infusion 5‐fluorouracil in advanced hormone refractory prostate cancer: An Illinois cancer center study'. Together they form a unique fingerprint.